ROC curves and area under curve (AUC) values also demonstrated the accuracy of TRIM56 in predicting the 1-, 3-, and 5-year OS of glioma, LGG, and GBM patients in CGGA_mRNAseq_325 (Supplementary Fig. 3I–K) and TCGA (Supplementary Fig. 3L–N) cohorts. Here, TRIM56 is linked to glioblastoma.